isg15依赖性USP18的稳定对于调节人类I型干扰素信号是必要的,但不是充分的

IF 4.5 3区 医学 Q2 IMMUNOLOGY
Andri Vasou, Katie Nightingale, Vladimíra Cetkovská, Jonathan Scheler, Connor G. G. Bamford, Jelena Andrejeva, Jessica C. Rowe, Kirby N. Swatek, Ulrich Schwarz-Linek, Richard E. Randall, John McLauchlan, Michael P. Weekes, Dusan Bogunovic, David J. Hughes
{"title":"isg15依赖性USP18的稳定对于调节人类I型干扰素信号是必要的,但不是充分的","authors":"Andri Vasou,&nbsp;Katie Nightingale,&nbsp;Vladimíra Cetkovská,&nbsp;Jonathan Scheler,&nbsp;Connor G. G. Bamford,&nbsp;Jelena Andrejeva,&nbsp;Jessica C. Rowe,&nbsp;Kirby N. Swatek,&nbsp;Ulrich Schwarz-Linek,&nbsp;Richard E. Randall,&nbsp;John McLauchlan,&nbsp;Michael P. Weekes,&nbsp;Dusan Bogunovic,&nbsp;David J. Hughes","doi":"10.1002/eji.202451651","DOIUrl":null,"url":null,"abstract":"<p>Type I interferon (IFN) signalling induces the expression of several hundred IFN-stimulated genes (ISGs) that provide an unfavourable environment for viral replication. To prevent an overexuberant response and autoinflammatory disease, IFN signalling requires tight control. One critical regulator is the ubiquitin-like protein IFN-stimulated gene 15 (ISG15), evidenced by autoinflammatory disease in patients with inherited ISG15 deficiencies. Current models suggest that ISG15 stabilises ubiquitin-specific peptidase 18 (USP18), a well-established negative regulator of IFN signalling. USP18 also functions as an ISG15-specific peptidase that cleaves ISG15 from ISGylated proteins; however, USP18's catalytic activity is dispensable for controlling IFN signalling. Here, we show that the ISG15-dependent stabilisation of USP18 involves hydrophobic interactions reliant on tryptophan 123 (W123) in ISG15. Nonetheless, while USP18 stabilisation is necessary, it is not sufficient for the regulation of IFN signalling; ISG15 C-terminal mutants with significantly reduced affinity still stabilised USP18, yet the magnitude of signalling resembled ISG15-deficient cells. Hence, USP18 requires non-covalent interactions with the ISG15 C-terminal diGlycine motif to promote its regulatory function. It shows ISG15 is a repressor of type I IFN signalling beyond its role as a USP18 stabiliser.</p>","PeriodicalId":165,"journal":{"name":"European Journal of Immunology","volume":"55 2","pages":""},"PeriodicalIF":4.5000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202451651","citationCount":"0","resultStr":"{\"title\":\"ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans\",\"authors\":\"Andri Vasou,&nbsp;Katie Nightingale,&nbsp;Vladimíra Cetkovská,&nbsp;Jonathan Scheler,&nbsp;Connor G. G. Bamford,&nbsp;Jelena Andrejeva,&nbsp;Jessica C. Rowe,&nbsp;Kirby N. Swatek,&nbsp;Ulrich Schwarz-Linek,&nbsp;Richard E. Randall,&nbsp;John McLauchlan,&nbsp;Michael P. Weekes,&nbsp;Dusan Bogunovic,&nbsp;David J. Hughes\",\"doi\":\"10.1002/eji.202451651\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Type I interferon (IFN) signalling induces the expression of several hundred IFN-stimulated genes (ISGs) that provide an unfavourable environment for viral replication. To prevent an overexuberant response and autoinflammatory disease, IFN signalling requires tight control. One critical regulator is the ubiquitin-like protein IFN-stimulated gene 15 (ISG15), evidenced by autoinflammatory disease in patients with inherited ISG15 deficiencies. Current models suggest that ISG15 stabilises ubiquitin-specific peptidase 18 (USP18), a well-established negative regulator of IFN signalling. USP18 also functions as an ISG15-specific peptidase that cleaves ISG15 from ISGylated proteins; however, USP18's catalytic activity is dispensable for controlling IFN signalling. Here, we show that the ISG15-dependent stabilisation of USP18 involves hydrophobic interactions reliant on tryptophan 123 (W123) in ISG15. Nonetheless, while USP18 stabilisation is necessary, it is not sufficient for the regulation of IFN signalling; ISG15 C-terminal mutants with significantly reduced affinity still stabilised USP18, yet the magnitude of signalling resembled ISG15-deficient cells. Hence, USP18 requires non-covalent interactions with the ISG15 C-terminal diGlycine motif to promote its regulatory function. It shows ISG15 is a repressor of type I IFN signalling beyond its role as a USP18 stabiliser.</p>\",\"PeriodicalId\":165,\"journal\":{\"name\":\"European Journal of Immunology\",\"volume\":\"55 2\",\"pages\":\"\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2025-02-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202451651\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/eji.202451651\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Immunology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/eji.202451651","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

I型干扰素(IFN)信号传导诱导数百种IFN刺激基因(isg)的表达,这些基因为病毒复制提供了不利的环境。为了防止过度反应和自身炎症性疾病,IFN信号需要严格控制。一个关键的调节因子是泛素样蛋白ifn刺激基因15 (ISG15),遗传ISG15缺乏患者的自身炎症性疾病证明了这一点。目前的模型表明,ISG15可以稳定泛素特异性肽酶18 (USP18),这是一种公认的IFN信号传导的负调节因子。USP18还作为ISG15特异性肽酶,从ISG15基化蛋白中切割ISG15;然而,USP18的催化活性对于控制IFN信号传导是必不可少的。在这里,我们发现USP18的ISG15依赖性稳定涉及ISG15中依赖色氨酸123 (W123)的疏水相互作用。尽管如此,虽然USP18的稳定是必要的,但它对于IFN信号的调节是不够的;亲和性显著降低的ISG15 c端突变体仍能稳定USP18,但信号传导的幅度与ISG15缺陷细胞相似。因此,USP18需要与ISG15 c端二甘氨酸基序进行非共价相互作用以促进其调控功能。它表明ISG15是I型IFN信号的抑制因子,而不是作为USP18稳定剂的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans

ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans

Type I interferon (IFN) signalling induces the expression of several hundred IFN-stimulated genes (ISGs) that provide an unfavourable environment for viral replication. To prevent an overexuberant response and autoinflammatory disease, IFN signalling requires tight control. One critical regulator is the ubiquitin-like protein IFN-stimulated gene 15 (ISG15), evidenced by autoinflammatory disease in patients with inherited ISG15 deficiencies. Current models suggest that ISG15 stabilises ubiquitin-specific peptidase 18 (USP18), a well-established negative regulator of IFN signalling. USP18 also functions as an ISG15-specific peptidase that cleaves ISG15 from ISGylated proteins; however, USP18's catalytic activity is dispensable for controlling IFN signalling. Here, we show that the ISG15-dependent stabilisation of USP18 involves hydrophobic interactions reliant on tryptophan 123 (W123) in ISG15. Nonetheless, while USP18 stabilisation is necessary, it is not sufficient for the regulation of IFN signalling; ISG15 C-terminal mutants with significantly reduced affinity still stabilised USP18, yet the magnitude of signalling resembled ISG15-deficient cells. Hence, USP18 requires non-covalent interactions with the ISG15 C-terminal diGlycine motif to promote its regulatory function. It shows ISG15 is a repressor of type I IFN signalling beyond its role as a USP18 stabiliser.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
8.30
自引率
3.70%
发文量
224
审稿时长
2 months
期刊介绍: The European Journal of Immunology (EJI) is an official journal of EFIS. Established in 1971, EJI continues to serve the needs of the global immunology community covering basic, translational and clinical research, ranging from adaptive and innate immunity through to vaccines and immunotherapy, cancer, autoimmunity, allergy and more. Mechanistic insights and thought-provoking immunological findings are of interest, as are studies using the latest omics technologies. We offer fast track review for competitive situations, including recently scooped papers, format free submission, transparent and fair peer review and more as detailed in our policies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信